Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-04-15 00:00:00 ET · period of report 2022-04-13 · accession 0001415889-22-004082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-15 | 2022-04-13 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $11.23 | +2,276 | 63.4K | +4% | +$25.6K |
| D | 2022-04-15 | 2022-04-13 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $45.17 | -2,276 | 61.1K | -4% | -$102.8K |
| D | 2022-04-15 | 2022-04-13 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $11.23 | -2,276 | 0 | -100% | -$25.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-13 | M | A | 2,276 | $11.23 | 63,386 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-13 | S | D | 2,276 | $45.17 | 61,110 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.35 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-04-13 | M | D | 2,276 | $11.23 | 0 | D | $11.23 · — to 2027-01-02 | 2,276 Common Stock | (F3) Currently exercisable. |